Financhill
Back

Kuros Biosciences Quote, Financials, Valuation and Earnings

Kuros Biosciences Price Quote

$22.57

Kuros Biosciences Key Stats

Buy
52
Kuros Biosciences (CSBTF) is a Buy

Day range:
$22.57 - $22.57
52-week range:
$3.85 - $36.10
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
14.26
P/B ratio:
12.44%

Volume:
0
Avg. volume:
1.1K
1-year change:
368.26%
Market cap:
$832.9M
Revenue:
$37.4M
EPS:
$-0.28

How Much Does Kuros Biosciences Make?

Is Kuros Biosciences Growing As A Company?

  • What Is Kuros Biosciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.03%
  • What Is Kuros Biosciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Kuros Biosciences Stock Price Performance

What Is Kuros Biosciences 52-Week High & Low?

Kuros Biosciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Kuros Biosciences?

  • How Much Debt Does Kuros Biosciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Kuros Biosciences Have?
    Cash and short term investments quarterly total is $15.9M
  • What Is Kuros Biosciences’s Book Value Per Share?
    Book value per share is 1.81

Is Kuros Biosciences Cash Flow Positive?

Data Unavailable

Kuros Biosciences Return On Invested Capital

  • Is Management Doing A Good Job?
    CSBTF return on invested capital is -14.62%
  • What Is Kuros Biosciences Return On Assets?
    ROA measures how assets are converting to revenues and is -11.65%
  • What Is CSBTF Return On Equity?
    ROE is a measure of profitability and is -14.62%

Kuros Biosciences Earnings Date & Stock Price

Kuros Biosciences Competitors

  • Who Are Kuros Biosciences's Competitors?
    Below is a list of companies who compete with Kuros Biosciences or are related in some way:
    • AC Immune SA (ACIU)
    • Addex Therapeutics Ltd (ADXN)
    • CRISPR Therapeutics AG (CRSP)
    • Molecular Partners AG (MOLN)
    • NLS Pharmaceutics Ltd (NLSP)

Kuros Biosciences Dividend Yield

Kuros Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 3.05% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many CSBTF shares are owned by institutional investors?
    3.6M CSBTF shares are owned by institutional investors
  • How many CSBTF shares are owned by insiders?
    0 CSBTF shares are owned by insiders